Prospects of plant-derived exosome-like nanocarriers in oncology and tissue engineering

• Published in: Human cell : official journal of Human Cell Research Society 2024-01, Vol.37 (1), p.121-138
• Main Authors: Rahmati, Shima, Karimi, Hafez, Alizadeh, Morteza, Khazaei, Amir Hossein, Paiva-Santos, Ana Cláudia, Rezakhani, Leila, Sharifi, Esmaeel
• Format: Article
• Language: English
• Subjects: Animals; Biomedical and Life Sciences; Cell Biology; Cell interactions; Drug delivery; Drug Delivery Systems; Exosomes; Exosomes - metabolism; Extracellular Vesicles; Gynecology; Immunogenicity; Life Sciences; Lipid bilayers; Mammalian cells; Mammals; Nanoparticles; Neoplasms - drug therapy; Neoplasms - metabolism; Oncology; Plants; Reproductive Medicine; Review Article; Separation techniques; Side effects; Stem Cells; Surgery; Tissue Engineering; Vesicles
• ISSN: 1749-0774; 0914-7470; 1749-0774
• DOI: 10.1007/s13577-023-00994-4

Almost all cell types, either in vivo or in vitro, create extracellular vesicles (EVs). Among them are exosomes (EXOs), i.e., tiny nanovesicles containing a lipid bilayer, proteins, and RNAs that are actively involved in cellular communication, indicating that they may be exploited as both diagnostics and therapeutics for conditions like cancer. These nanoparticles can also be used as nanocarriers in many types of research to carry agents such as drugs. Plant-derived exosome-like nanoparticles (PENs) are currently under investigation as a substitute for EXOs formed from mammalian cells, allowing researchers to get beyond the technical constraints of mammalian vesicles. Because of their physiological, chemical, and biological properties, PENs have a lot of promise for use as nanocarriers in drug delivery systems that can deliver various dosages, especially when it comes to large-scale repeatability. The present study has looked at the origins and isolation techniques of PENs, their anticancer properties, their usage as nanocarriers in the treatment of different illnesses, and their antioxidant properties. These nanoparticles can aid in the achievement of therapeutic objectives, as they have benign, non-immunogenic side effects and can pass biological barriers. Time-consuming and perhaps damaging PEN separation techniques is used. For the current PEN separation techniques to be used in commercial and therapeutic settings, they must be altered. In this regard, the concurrent application of biological sciences can be beneficial for improving PEN separation techniques. PENs’ innate metabolic properties provide them a great deal of promise for application in drug delivery systems. However, there could be a risk to both the loaded medications and the intrinsic bioactive components if these particles are heavily armed with drugs. Therefore, to prevent these side effects, more studies are needed to devise sophisticated drug-loading procedures and to learn more about the physiology of PENs. Graphical Abstract